PRS46 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI IN PATIENTS WITH COPD- COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2440
https://www.valueinhealthjournal.com/article/S1098-3015(18)35742-5/fulltext
Title :
PRS46 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI IN PATIENTS WITH COPD- COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35742-5&doi=10.1016/j.jval.2018.09.2440
First page :
Section Title :
Open access? :
No
Section Order :
1797